Connected Health Pulse

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

tag breast-cancer

Doing Less Can Be Doing More for Healthcare – the Biggest Takeaway From ASCO 2018

Health Populi

JUNE 5, 2018

Groundbreaking research presented at this week’s ASCO meeting found that some women diagnosed with certain forms of cancer do not benefit from undergoing chemotherapy. The test is called the Oncotype DX Breast Recurrence Score. The second chart illustrates patient-borne costs for early stage breast cancer.

Medical Billing

Medical Billing Primary Care Pharmaceuticals

$100+ Billion spent on myriad of acquisitions across Pharma and Biotech industries in H1 2018

Lloyd Price

JULY 5, 2018

As BioSpace noted when the deal was announced, Takeda will also take on a significant amount of debt through the deal, sending the price tag closer to $80 billion when that amount is included. The deal will help open U.S. markets for Japan-based Takeda and Shire’s drugs will have easier access to markets in Japan.

BioTech

Doing Less Can Be Doing More for Healthcare – the Biggest Takeaway From ASCO 2018

$100+ Billion spent on myriad of acquisitions across Pharma and Biotech industries in H1 2018

Stay Connected